These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26474449)

  • 1. Practical Experience of the Application of a Weighted Burden Test to Whole Exome Sequence Data for Obesity and Schizophrenia.
    Curtis D;
    Ann Hum Genet; 2016 Jan; 80(1):38-49. PubMed ID: 26474449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of an Exome-Wide Risk Score for Schizophrenia Based on a Weighted Burden Test.
    Curtis D
    Ann Hum Genet; 2018 Jan; 82(1):11-22. PubMed ID: 28895126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weighted burden analysis in 200,000 exome-sequenced subjects characterises rare variant effects on BMI.
    Curtis D
    Int J Obes (Lond); 2022 Apr; 46(4):782-792. PubMed ID: 35067685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Recessive Effects in Schizophrenia Using Next-Generation Exome Sequence Data.
    Curtis D
    Ann Hum Genet; 2015 Sep; 79(5):313-319. PubMed ID: 25817274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families.
    Timms AE; Dorschner MO; Wechsler J; Choi KY; Kirkwood R; Girirajan S; Baker C; Eichler EE; Korvatska O; Roche KW; Horwitz MS; Tsuang DW
    JAMA Psychiatry; 2013 Jun; 70(6):582-90. PubMed ID: 23553203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome sequence analysis and follow up genotyping implicates rare ULK1 variants to be involved in susceptibility to schizophrenia.
    Al Eissa MM; Fiorentino A; Sharp SI; O'Brien NL; Wolfe K; Giaroli G; Curtis D; Bass NJ; McQuillin A
    Ann Hum Genet; 2018 Mar; 82(2):88-92. PubMed ID: 29148569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathway analysis of whole exome sequence data provides further support for the involvement of histone modification in the aetiology of schizophrenia.
    Curtis D
    Psychiatr Genet; 2016 Oct; 26(5):223-7. PubMed ID: 26981879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Non-Variant Sites to Improve the Clinical Assessment of Whole-Genome Sequence Data.
    Ferrarini A; Xumerle L; Griggio F; Garonzi M; Cantaloni C; Centomo C; Vargas SM; Descombes P; Marquis J; Collino S; Franceschi C; Garagnani P; Salisbury BA; Harvey JM; Delledonne M
    PLoS One; 2015; 10(7):e0132180. PubMed ID: 26147798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Power of Exome Chips.
    Page CM; Baranzini SE; Mevik BH; Bos SD; Harbo HF; Andreassen BK
    PLoS One; 2015; 10(10):e0139642. PubMed ID: 26437075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing followed by genotyping suggests SYPL2 as a susceptibility gene for morbid obesity.
    Jiao H; Arner P; Gerdhem P; Strawbridge RJ; Näslund E; Thorell A; Hamsten A; Kere J; Dahlman I
    Eur J Hum Genet; 2015 Sep; 23(9):1216-22. PubMed ID: 25406998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of weighting schemes based on allele frequency and annotation for weighted burden association analysis of complex phenotypes.
    Curtis D
    Gene; 2022 Jan; 809():146039. PubMed ID: 34688815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extreme-phenotype genome-wide association study (XP-GWAS): a method for identifying trait-associated variants by sequencing pools of individuals selected from a diversity panel.
    Yang J; Jiang H; Yeh CT; Yu J; Jeddeloh JA; Nettleton D; Schnable PS
    Plant J; 2015 Nov; 84(3):587-96. PubMed ID: 26386250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare-variant genome-wide association studies: a new frontier in genetic analysis of complex traits.
    Wagner MJ
    Pharmacogenomics; 2013 Mar; 14(4):413-24. PubMed ID: 23438888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome.
    Chen MJ; Wei SY; Yang WS; Wu TT; Li HY; Ho HN; Yang YS; Chen PL
    Hum Reprod; 2015 Jul; 30(7):1732-42. PubMed ID: 25924657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New technologies provide insights into genetic basis of psychiatric disorders and explain their co-morbidity.
    Rudan I
    Psychiatr Danub; 2010 Jun; 22(2):190-2. PubMed ID: 20562745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome sequencing analysis: a guide to disease variant detection.
    Isakov O; Perrone M; Shomron N
    Methods Mol Biol; 2013; 1038():137-58. PubMed ID: 23872973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extreme obesity is associated with variation in genes related to the circadian rhythm of food intake and hypothalamic signaling.
    Mariman EC; Bouwman FG; Aller EE; van Baak MA; Wang P
    Physiol Genomics; 2015 Jun; 47(6):225-31. PubMed ID: 25805767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome versus transcriptome sequencing in identifying coding region variants.
    Ku CS; Wu M; Cooper DN; Naidoo N; Pawitan Y; Pang B; Iacopetta B; Soong R
    Expert Rev Mol Diagn; 2012 Apr; 12(3):241-51. PubMed ID: 22468815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What can exome sequencing do for you?
    Majewski J; Schwartzentruber J; Lalonde E; Montpetit A; Jabado N
    J Med Genet; 2011 Sep; 48(9):580-9. PubMed ID: 21730106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study of schizophrenia with variants in miR-137 binding sites.
    Curtis D; Emmett W
    Schizophr Res; 2018 Jul; 197():346-348. PubMed ID: 29158013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.